Proactiveinvestors USA & Canada Humanigen, Inc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Humanigen, Inc. RSS feed en Fri, 04 Dec 2020 22:07:41 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Humanigen showing positive results for cancer drug lenzilumab, also used to treat patients hospitalized with coronavirus https://www.proactiveinvestors.com/companies/news/215256/humanigen-showing-positive-results-for-cancer-drug-lenzilumab-also-used-to-treat-patients-hospitalized-with-coronavirus-215256.html Wed, 25 Nov 2020 12:20:00 -0500 https://www.proactiveinvestors.com/companies/news/215256/humanigen-showing-positive-results-for-cancer-drug-lenzilumab-also-used-to-treat-patients-hospitalized-with-coronavirus-215256.html Humanigen creates Australian entity to help drive Asia-Pacific growth https://www.proactiveinvestors.com/companies/news/934701/humanigen-creates-australian-entity-to-help-drive-asia-pacific-growth-934701.html Mon, 23 Nov 2020 21:52:00 -0500 https://www.proactiveinvestors.com/companies/news/934701/humanigen-creates-australian-entity-to-help-drive-asia-pacific-growth-934701.html Humanigen ends 3Q with $91.4M following positive COVID-19 trial results https://www.proactiveinvestors.com/companies/news/933714/humanigen-ends-3q-with-914m-following-positive-covid-19-trial-results-933714.html Wed, 11 Nov 2020 14:15:00 -0500 https://www.proactiveinvestors.com/companies/news/933714/humanigen-ends-3q-with-914m-following-positive-covid-19-trial-results-933714.html Humanigen announces positive interim Phase 3 data on lenzilumab to treat patients hospitalized with COVID-19 https://www.proactiveinvestors.com/companies/news/933350/humanigen-announces-positive-interim-phase-3-data-on-lenzilumab-to-treat-patients-hospitalized-with-covid-19-933350.html Fri, 06 Nov 2020 18:15:00 -0500 https://www.proactiveinvestors.com/companies/news/933350/humanigen-announces-positive-interim-phase-3-data-on-lenzilumab-to-treat-patients-hospitalized-with-covid-19-933350.html Humanigen inks licensing deal for coronavirus drug lenzilumab in South Korea and the Philippines https://www.proactiveinvestors.com/companies/news/933051/humanigen-inks-licensing-deal-for-coronavirus-drug-lenzilumab-in-south-korea-and-the-philippines-933051.html Tue, 03 Nov 2020 14:16:00 -0500 https://www.proactiveinvestors.com/companies/news/933051/humanigen-inks-licensing-deal-for-coronavirus-drug-lenzilumab-in-south-korea-and-the-philippines-933051.html Humanigen says MedStar Washington Hospital Center in Washington, DC treats its first COVID-19 patient with lenzilumab https://www.proactiveinvestors.com/companies/news/932855/humanigen-says-medstar-washington-hospital-center-in-washington-dc-treats-its-first-covid-19-patient-with-lenzilumab-932855.html Fri, 30 Oct 2020 18:58:00 -0400 https://www.proactiveinvestors.com/companies/news/932855/humanigen-says-medstar-washington-hospital-center-in-washington-dc-treats-its-first-covid-19-patient-with-lenzilumab-932855.html Humanigen says first patient dosed in NIH-run ACTIV-5 ‘Big Effect Trial’ evaluating lenzilumab for COVID-19 https://www.proactiveinvestors.com/companies/news/932714/humanigen-says-first-patient-dosed-in-nih-run-activ-5-big-effect-trial-evaluating-lenzilumab-for-covid-19-932714.html Fri, 30 Oct 2020 17:14:00 -0400 https://www.proactiveinvestors.com/companies/news/932714/humanigen-says-first-patient-dosed-in-nih-run-activ-5-big-effect-trial-evaluating-lenzilumab-for-covid-19-932714.html Humanigen gets positive feedback from FDA ahead of emergency use application for coronavirus drug lenzilumab https://www.proactiveinvestors.com/companies/news/930579/humanigen-gets-positive-feedback-from-fda-ahead-of-emergency-use-application-for-coronavirus-drug-lenzilumab-930579.html Fri, 02 Oct 2020 13:44:00 -0400 https://www.proactiveinvestors.com/companies/news/930579/humanigen-gets-positive-feedback-from-fda-ahead-of-emergency-use-application-for-coronavirus-drug-lenzilumab-930579.html Humanigen secures $72M offering to fund development of coronavirus treatment lenzilumab https://www.proactiveinvestors.com/companies/news/929726/humanigen-secures-72m-offering-to-fund-development-of-coronavirus-treatment-lenzilumab-929726.html Tue, 22 Sep 2020 19:47:00 -0400 https://www.proactiveinvestors.com/companies/news/929726/humanigen-secures-72m-offering-to-fund-development-of-coronavirus-treatment-lenzilumab-929726.html Humanigen prices underwritten public offering of 8 million shares to raise $68M as it preps for Nasdaq debut https://www.proactiveinvestors.com/companies/news/929447/humanigen-prices-underwritten-public-offering-of-8-million-shares-to-raise-68m-as-it-preps-for-nasdaq-debut-929447.html Fri, 18 Sep 2020 12:28:00 -0400 https://www.proactiveinvestors.com/companies/news/929447/humanigen-prices-underwritten-public-offering-of-8-million-shares-to-raise-68m-as-it-preps-for-nasdaq-debut-929447.html NA Proactive news snapshot: IEC Electronics, Innocan Pharma, Ion Energy, Alchemist Mining UPDATE ... https://www.proactiveinvestors.com/companies/news/929128/na-proactive-news-snapshot-iec-electronics-innocan-pharma-ion-energy-alchemist-mining-update--929128.html Tue, 15 Sep 2020 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/929128/na-proactive-news-snapshot-iec-electronics-innocan-pharma-ion-energy-alchemist-mining-update--929128.html Humanigen launches public offering of 8 million shares to finance lenzilumab as potential therapy for COVID-19 patients https://www.proactiveinvestors.com/companies/news/929113/humanigen-launches-public-offering-of-8-million-shares-to-finance-lenzilumab-as-potential-therapy-for-covid-19-patients-929113.html Tue, 15 Sep 2020 12:45:00 -0400 https://www.proactiveinvestors.com/companies/news/929113/humanigen-launches-public-offering-of-8-million-shares-to-finance-lenzilumab-as-potential-therapy-for-covid-19-patients-929113.html Humanigen and Lonza reveal collaboration to expand manufacturing COVID-19 therapeutic candidate lenzilumab https://www.proactiveinvestors.com/companies/news/929109/humanigen-and-lonza-reveal-collaboration-to-expand-manufacturing-covid-19-therapeutic-candidate-lenzilumab-929109.html Tue, 15 Sep 2020 12:18:00 -0400 https://www.proactiveinvestors.com/companies/news/929109/humanigen-and-lonza-reveal-collaboration-to-expand-manufacturing-covid-19-therapeutic-candidate-lenzilumab-929109.html Humanigen says review of lenzilumab Phase 3 study of COVID-19 by data safety monitoring board gets green light to continue https://www.proactiveinvestors.com/companies/news/928995/humanigen-says-review-of-lenzilumab-phase-3-study-of-covid-19-by-data-safety-monitoring-board-gets-green-light-to-continue-928995.html Mon, 14 Sep 2020 13:23:00 -0400 https://www.proactiveinvestors.com/companies/news/928995/humanigen-says-review-of-lenzilumab-phase-3-study-of-covid-19-by-data-safety-monitoring-board-gets-green-light-to-continue-928995.html Humanigen plans 1:5 reverse stock split ahead of potential uplisting to Nasdaq exchange https://www.proactiveinvestors.com/companies/news/928415/humanigen-plans-15-reverse-stock-split-ahead-of-potential-uplisting-to-nasdaq-exchange-928415.html Mon, 07 Sep 2020 11:24:00 -0400 https://www.proactiveinvestors.com/companies/news/928415/humanigen-plans-15-reverse-stock-split-ahead-of-potential-uplisting-to-nasdaq-exchange-928415.html Humanigen says lenzilumab demonstrated 80% reduction in relative risk of invasive mechanical ventilation and/or death in coronavirus patients https://www.proactiveinvestors.com/companies/news/927997/humanigen-says-lenzilumab-demonstrated-80-reduction-in-relative-risk-of-invasive-mechanical-ventilation-andor-death-in-coronavirus-patients-927997.html Tue, 01 Sep 2020 13:30:00 -0400 https://www.proactiveinvestors.com/companies/news/927997/humanigen-says-lenzilumab-demonstrated-80-reduction-in-relative-risk-of-invasive-mechanical-ventilation-andor-death-in-coronavirus-patients-927997.html Humanigen taps drug development expert Edward Jordan for chief commercial officer role ahead of lenzilumab launch https://www.proactiveinvestors.com/companies/news/927384/humanigen-taps-drug-development-expert-edward-jordan-for-chief-commercial-officer-role-ahead-of-lenzilumab-launch-927384.html Mon, 24 Aug 2020 13:30:00 -0400 https://www.proactiveinvestors.com/companies/news/927384/humanigen-taps-drug-development-expert-edward-jordan-for-chief-commercial-officer-role-ahead-of-lenzilumab-launch-927384.html Humanigen gets regulatory nod to begin Phase 3 coronavirus trial of lenzilumab in Brazil https://www.proactiveinvestors.com/companies/news/926261/humanigen-gets-regulatory-nod-to-begin-phase-3-coronavirus-trial-of-lenzilumab-in-brazil-926261.html Mon, 10 Aug 2020 12:55:00 -0400 https://www.proactiveinvestors.com/companies/news/926261/humanigen-gets-regulatory-nod-to-begin-phase-3-coronavirus-trial-of-lenzilumab-in-brazil-926261.html Humanigen appoints experienced healthcare executive, Bob Atwill to newly created role of Head of Asia-Pacific https://www.proactiveinvestors.com/companies/news/926039/humanigen-appoints-experienced-healthcare-executive-bob-atwill-to-newly-created-role-of-head-of-asia-pacific-926039.html Thu, 06 Aug 2020 13:06:00 -0400 https://www.proactiveinvestors.com/companies/news/926039/humanigen-appoints-experienced-healthcare-executive-bob-atwill-to-newly-created-role-of-head-of-asia-pacific-926039.html Humanigen taps biotech veteran Timothy Morris to dual CFO/COO role https://www.proactiveinvestors.com/companies/news/925707/humanigen-taps-biotech-veteran-timothy-morris-to-dual-cfocoo-role-925707.html Mon, 03 Aug 2020 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/925707/humanigen-taps-biotech-veteran-timothy-morris-to-dual-cfocoo-role-925707.html Humanigen chosen by National Institute of Health's upcoming coronavirus clinical trial https://www.proactiveinvestors.com/companies/news/925620/humanigen-chosen-by-national-institute-of-health-s-upcoming-coronavirus-clinical-trial-925620.html Fri, 31 Jul 2020 14:40:00 -0400 https://www.proactiveinvestors.com/companies/news/925620/humanigen-chosen-by-national-institute-of-health-s-upcoming-coronavirus-clinical-trial-925620.html Humanigen says lenzilumab selected for National Institute of Health's upcoming coronavirus clinical trial https://www.proactiveinvestors.com/companies/news/925175/humanigen-says-lenzilumab-selected-for-national-institute-of-health-s-upcoming-coronavirus-clinical-trial-925175.html Mon, 27 Jul 2020 20:32:00 -0400 https://www.proactiveinvestors.com/companies/news/925175/humanigen-says-lenzilumab-selected-for-national-institute-of-health-s-upcoming-coronavirus-clinical-trial-925175.html Humanigen bolsters partnership with Catalent to produce lenzilumab for coronavirus trials https://www.proactiveinvestors.com/companies/news/924388/humanigen-bolsters-partnership-with-catalent-to-produce-lenzilumab-for-coronavirus-trials-924388.html Thu, 16 Jul 2020 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/924388/humanigen-bolsters-partnership-with-catalent-to-produce-lenzilumab-for-coronavirus-trials-924388.html Humanigen strengthens leadership team with three new executive appointments https://www.proactiveinvestors.com/companies/news/923647/humanigen-strengthens-leadership-team-with-three-new-executive-appointments-923647.html Tue, 07 Jul 2020 15:35:00 -0400 https://www.proactiveinvestors.com/companies/news/923647/humanigen-strengthens-leadership-team-with-three-new-executive-appointments-923647.html NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE … https://www.proactiveinvestors.com/companies/news/923117/na-proactive-news-snapshot-milestone-scientific-betterlife-pharma-revive-therapeutics-matinas-biopharma-biocept-update--923117.html Tue, 30 Jun 2020 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/923117/na-proactive-news-snapshot-milestone-scientific-betterlife-pharma-revive-therapeutics-matinas-biopharma-biocept-update--923117.html Humanigen reveals first patient has been infused in ZUMA-19 study https://www.proactiveinvestors.com/companies/news/923093/humanigen-reveals-first-patient-has-been-infused-in-zuma-19-study-923093.html Tue, 30 Jun 2020 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/923093/humanigen-reveals-first-patient-has-been-infused-in-zuma-19-study-923093.html Humanigen says lenzilumab drug delivers better recovery time for coronavirus-associated pneumonia in cross-trial analysis https://www.proactiveinvestors.com/companies/news/922031/humanigen-says-lenzilumab-drug-delivers-better-recovery-time-for-coronavirus-associated-pneumonia-in-cross-trial-analysis-922031.html Tue, 16 Jun 2020 12:50:00 -0400 https://www.proactiveinvestors.com/companies/news/922031/humanigen-says-lenzilumab-drug-delivers-better-recovery-time-for-coronavirus-associated-pneumonia-in-cross-trial-analysis-922031.html NA Proactive news snapshot: VR Resources, Ideanomics, AIM ImmunoTech, ImagineAR, Exactus, mCloud Technologies UPDATE … https://www.proactiveinvestors.com/companies/news/921921/na-proactive-news-snapshot-vr-resources-ideanomics-aim-immunotech-imaginear-exactus-mcloud-technologies-update--921921.html Mon, 15 Jun 2020 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/921921/na-proactive-news-snapshot-vr-resources-ideanomics-aim-immunotech-imaginear-exactus-mcloud-technologies-update--921921.html Humanigen sees 12 patients with coronavirus pneumonia recover after lenzilumab treatment in Mayo Clinic study https://www.proactiveinvestors.com/companies/news/921915/humanigen-sees-12-patients-with-coronavirus-pneumonia-recover-after-lenzilumab-treatment-in-mayo-clinic-study-921915.html Mon, 15 Jun 2020 11:43:00 -0400 https://www.proactiveinvestors.com/companies/news/921915/humanigen-sees-12-patients-with-coronavirus-pneumonia-recover-after-lenzilumab-treatment-in-mayo-clinic-study-921915.html Humanigen announces 71.8 million dollars in financing https://www.proactiveinvestors.com/companies/news/921076/humanigen-announces-718-million-dollars-in-financing-921076.html Wed, 03 Jun 2020 18:09:00 -0400 https://www.proactiveinvestors.com/companies/news/921076/humanigen-announces-718-million-dollars-in-financing-921076.html